Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab

NCT00077987 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00077987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
April 30, 2005
Enrollment
84
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms